Advanced biomaterial agent from chitosan/poloxamer 407-based thermosensitive hydrogen containing biosynthesized silver nanoparticles using Eucalyptus camaldulensis leaf extract

PLoS One. 2023 Oct 20;18(10):e0291505. doi: 10.1371/journal.pone.0291505. eCollection 2023.

Abstract

Context: The emergence of multidrug-resistant (MDR) pathogens poses a significant challenge for global public health systems, increasing hospital morbidity and mortality and prolonged hospitalization.

Objective: We evaluated the antimicrobial activity of a thermosensitive hydrogel containing bio-synthesized silver nanoparticles (bio-AgNPs) based on chitosan/poloxamer 407 using a leaf extract of Eucalyptus calmadulensis.

Results: The thermosensitive hydrogel was prepared by a cold method after mixing the ingredients and left at 4°C overnight to ensure the complete solubilization of poloxamer 407. The stability of the hydrogel formulation was evaluated at room temperature for 3 months, and the absorption peak (420 nm) of the NPs remained unchanged. The hydrogel formulation demonstrated rapid gelation under physiological conditions, excellent water retention (85%), and broad-spectrum antimicrobial activity against MDR clinical isolates and ATCC strains. In this regard, minimum inhibitory concentration and minimum microbial concentration values of the bio-AgNPs ranged from 2-8 μg/mL to 8-128 μg/mL, respectively. Formulation at concentrations <64 μg/mL showed no cytotoxic effect on human-derived macrophages (THP-1 cells) with no induction of inflammation.

Conclusions: The formulated hydrogel could be used in biomedical applications as it possesses a broad antimicrobial spectrum and anti-inflammatory properties without toxic effects on human cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Anti-Infective Agents* / pharmacology
  • Biocompatible Materials
  • Chitosan* / pharmacology
  • Eucalyptus*
  • Humans
  • Hydrogels
  • Metal Nanoparticles*
  • Microbial Sensitivity Tests
  • Plant Extracts / pharmacology
  • Poloxamer
  • Silver / pharmacology

Substances

  • Chitosan
  • Poloxamer
  • Silver
  • Biocompatible Materials
  • Anti-Infective Agents
  • Hydrogels
  • Plant Extracts
  • Anti-Bacterial Agents

Grants and funding

This study was funded by the National Research Council of Thailand (Grant No. N41A640071) and the Research and Researcher for Industry-RRI Ph.D. Program (Grant No. PHD61I0030), the Thailand Research Fund to S.W. Also, funding was provided by the Antibody Engineering and Proteomics Facility, Immune and Infection Research Centre, University of British Columbia Vancouver, BC, Canada to H.B.